PUB - Publikationen an der Universität Bielefeld

A neuroscience perspective of the gut theory of Parkinson's disease.
Smith LM, Parr-Brownlie LC., Eur J Neurosci 49(6), 2019
PMID: 29446158

Photobiomodulation of the microbiome: implications for metabolic and inflammatory diseases.
Bicknell B, Liebert A, Johnstone D, Kiat H., Lasers Med Sci 34(2), 2019
PMID: 30074108

Humanizing the gut microbiota of mice: Opportunities and challenges.
Lundberg R., Lab Anim 53(3), 2019
PMID: 30089440

The mammalian mycobiome: A complex system in a dynamic relationship with the host.
Lai GC, Tan TG, Pavelka N., Wiley Interdiscip Rev Syst Biol Med 11(1), 2019
PMID: 30255552

The contribution of the gut microbiome to neurodevelopment and neuropsychiatric disorders.
Warner BB., Pediatr Res 85(2), 2019
PMID: 30283047

Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease.
Maraki MI, Yannakoulia M, Stamelou M, Stefanis L, Xiromerisiou G, Kosmidis MH, Dardiotis E, Hadjigeorgiou GM, Sakka P, Anastasiou CA, Simopoulou E, Scarmeas N., Mov Disord 34(1), 2019
PMID: 30306634

The Effects of Probiotic Formulation Pretreatment (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) on a Lipopolysaccharide Rat Model.
Mohammadi G, Dargahi L, Peymani A, Mirzanejad Y, Alizadeh SA, Naserpour T, Nassiri-Asl M., J Am Coll Nutr 38(3), 2019
PMID: 30307792

Enlisting commensal microbes to resist antibiotic-resistant pathogens.
Keith JW, Pamer EG., J Exp Med 216(1), 2019
PMID: 30309968

Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.
Johnson ME, Stecher B, Labrie V, Brundin L, Brundin P., Trends Neurosci 42(1), 2019
PMID: 30342839

Microbiome-microglia connections via the gut-brain axis.
Abdel-Haq R, Schlachetzki JCM, Glass CK, Mazmanian SK., J Exp Med 216(1), 2019
PMID: 30385457

Making Sense of … the Microbiome in Psychiatry.
Bastiaanssen TFS, Cowan CSM, Claesson MJ, Dinan TG, Cryan JF., Int J Neuropsychopharmacol 22(1), 2019
PMID: 30099552

Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics.
Maguire M, Maguire G., Rev Neurosci 30(2), 2019
PMID: 30173208

Brain-Gut-Microbiota Axis in Alzheimer's Disease.
Kowalski K, Mulak A., J Neurogastroenterol Motil 25(1), 2019
PMID: 30646475

The gut microbiome of healthy long-living people.
Deng F, Li Y, Zhao J., Aging (Albany NY) 11(2), 2019
PMID: 30648974

Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in Mice.
Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ., Immunity 50(1), 2019
PMID: 30650377

The Dimension of Time in Host-Microbiome Interactions.
Uhr GT, Dohnalová L, Thaiss CA., mSystems 4(1), 2019
PMID: 30801030

Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's disease.
van Kessel SP, Frye AK, El-Gendy AO, Castejon M, Keshavarzian A, van Dijk G, El Aidy S., Nat Commun 10(1), 2019
PMID: 30659181

Gut microbiota density influences host physiology and is shaped by host and microbial factors.
Contijoch EJ, Britton GJ, Yang C, Mogno I, Li Z, Ng R, Llewellyn SR, Hira S, Johnson C, Rabinowitz KM, Barkan R, Dotan I, Hirten RP, Fu SC, Luo Y, Yang N, Luong T, Labrias PR, Lira S, Peter I, Grinspan A, Clemente JC, Kosoy R, Kim-Schulze S, Qin X, Castillo A, Hurley A, Atreja A, Rogers J, Fasihuddin F, Saliaj M, Nolan A, Reyes-Mercedes P, Rodriguez C, Aly S, Santa-Cruz K, Peters L, Suárez-Fariñas M, Huang R, Hao K, Zhu J, Zhang B, Losic B, Irizar H, Song WM, Di Narzo A, Wang W, Cohen BL, DiMaio C, Greenwald D, Itzkowitz S, Lucas A, Marion J, Maser E, Ungaro R, Naymagon S, Novak J, Shah B, Ullman T, Rubin P, George J, Legnani P, Telesco SE, Friedman JR, Brodmerkel C, Plevy S, Cho JH, Colombel JF, Schadt EE, Argmann C, Dubinsky M, Kasarskis A, Sands B, Faith JJ., Elife 8(), 2019
PMID: 30666957

Fecal microbiota changes associated with dehorning and castration stress primarily affects light-weight dairy calves.
Mir RA, Kleinhenz MD, Coetzee JF, Allen HK, Kudva IT., PLoS One 14(1), 2019
PMID: 30673718

Fto Deficiency Reduces Anxiety- and Depression-Like Behaviors in Mice via Alterations in Gut Microbiota.
Sun L, Ma L, Zhang H, Cao Y, Wang C, Hou N, Huang N, von Deneen KM, Zhao C, Shi Y, Pan Y, Wang M, Ji G, Nie Y., Theranostics 9(3), 2019
PMID: 30809304

Oral neonatal antibiotic treatment perturbs gut microbiota and aggravates central nervous system autoimmunity in Dark Agouti rats.
Stanisavljević S, Čepić A, Bojić S, Veljović K, Mihajlović S, Đedović N, Jevtić B, Momčilović M, Lazarević M, Mostarica Stojković M, Miljković Đ, Golić N., Sci Rep 9(1), 2019
PMID: 30696913

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson's Disease.
Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L., Cells 8(2), 2019
PMID: 30708997

[The gut microbiome in Parkinson's disease].
Bedarf JR, Hildebrand F, Goeser F, Bork P, Wüllner U., Nervenarzt 90(2), 2019
PMID: 30171304

The gut microbiome from patients with schizophrenia modulates the glutamate-glutamine-GABA cycle and schizophrenia-relevant behaviors in mice.
Zheng P, Zeng B, Liu M, Chen J, Pan J, Han Y, Liu Y, Cheng K, Zhou C, Wang H, Zhou X, Gui S, Perry SW, Wong ML, Licinio J, Wei H, Xie P., Sci Adv 5(2), 2019
PMID: 30775438

T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease.
Campos-Acuña J, Elgueta D, Pacheco R., Front Immunol 10(), 2019
PMID: 30828335

Glabridin Prevents Doxorubicin-Induced Cardiotoxicity Through Gut Microbiota Modulation and Colonic Macrophage Polarization in Mice.
Huang K, Liu Y, Tang H, Qiu M, Li C, Duan C, Wang C, Yang J, Zhou X., Front Pharmacol 10(), 2019
PMID: 30833897

Metabolomics-based identification of metabolic alterations in PARK2.
Okuzumi A, Hatano T, Ueno SI, Ogawa T, Saiki S, Mori A, Koinuma T, Oji Y, Ishikawa KI, Fujimaki M, Sato S, Ramamoorthy S, Mohney RP, Hattori N., Ann Clin Transl Neurol 6(3), 2019
PMID: 30911576

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.
Garretti F, Agalliu D, Lindestam Arlehamn CS, Sette A, Sulzer D., Front Immunol 10(), 2019
PMID: 30858851

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis.
Ma Q, Xing C, Long W, Wang HY, Liu Q, Wang RF., J Neuroinflammation 16(1), 2019
PMID: 30823925

Probiotic Bifidobacterium lactis V9 Regulates the Secretion of Sex Hormones in Polycystic Ovary Syndrome Patients through the Gut-Brain Axis.
Zhang J, Sun Z, Jiang S, Bai X, Ma C, Peng Q, Chen K, Chang H, Fang T, Zhang H., mSystems 4(2), 2019
PMID: 31020040

Daiokanzoto (Da-Huang-Gan-Cao-Tang) is an effective laxative in gut microbiota associated with constipation.
Takayama K, Takahara C, Tabuchi N, Okamura N., Sci Rep 9(1), 2019
PMID: 30846728

Microbiome, Parkinson's Disease and Molecular Mimicry.
Miraglia F, Colla E., Cells 8(3), 2019
PMID: 30866550

DL-3-n-butylphthalide therapy for Parkinson's disease: A randomized controlled trial.
Zhou H, Ye M, Xu W, Yu M, Liu X, Chen Y., Exp Ther Med 17(5), 2019
PMID: 30988766

Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
Kadowaki A, Saga R, Lin Y, Sato W, Yamamura T., Brain 142(4), 2019
PMID: 30770703

LRRK2 in Infection: Friend or Foe?
Herbst S, Gutierrez MG., ACS Infect Dis 5(6), 2019
PMID: 30915830

APOE genotype influences the gut microbiome structure and function in humans and mice: relevance for Alzheimer's disease pathophysiology.
Tran TTT, Corsini S, Kellingray L, Hegarty C, Le Gall G, Narbad A, Müller M, Tejera N, O'Toole PW, Minihane AM, Vauzour D., FASEB J 33(7), 2019
PMID: 30958695

Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease.
Bajracharya R, Youngson NA, Ballard JWO., Int J Mol Sci 20(8), 2019
PMID: 30991634

Dietary Modulation of Intestinal Microbiota: Future Opportunities in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Fan Y, Zhang J., Front Microbiol 10(), 2019
PMID: 31040833

Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease.
Fitzgerald E, Murphy S, Martinson HA., Front Neurosci 13(), 2019
PMID: 31068777

Spreading of α-Synuclein and Tau: A Systematic Comparison of the Mechanisms Involved.
Vasili E, Dominguez-Meijide A, Outeiro TF., Front Mol Neurosci 12(), 2019
PMID: 31105524

Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model.
Elgueta D, Contreras F, Prado C, Montoya A, Ugalde V, Chovar O, Villagra R, Henríquez C, Abellanas MA, Aymerich MS, Franco R, Pacheco R., Front Immunol 10(), 2019
PMID: 31118938

Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence.
Magistrelli L, Amoruso A, Mogna L, Graziano T, Cantello R, Pane M, Comi C., Front Immunol 10(), 2019
PMID: 31134068

Factors Associated With Dyskinesia in Parkinson's Disease in Mainland China.
Zhou X, Guo J, Sun Q, Xu Q, Pan H, Yu R, Tan J, Yan X, Tang B, Fang L., Front Neurol 10(), 2019
PMID: 31164859

Peli1 controls the survival of dopaminergic neurons through modulating microglia-mediated neuroinflammation.
Dai D, Yuan J, Wang Y, Xu J, Mao C, Xiao Y., Sci Rep 9(1), 2019
PMID: 31142803

Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease.
Chiang HL, Lin CH., J Mov Disord 12(2), 2019
PMID: 31158941

Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report.
Huang H, Xu H, Luo Q, He J, Li M, Chen H, Tang W, Nie Y, Zhou Y., Medicine (Baltimore) 98(26), 2019
PMID: 31261545

The Gut and Parkinson's Disease-A Bidirectional Pathway.
Santos SF, de Oliveira HL, Yamada ES, Neves BC, Pereira A., Front Neurol 10(), 2019
PMID: 31214110

Frailty, Cognitive Decline, Neurodegenerative Diseases and Nutrition Interventions.
Gómez-Gómez ME, Zapico SC., Int J Mol Sci 20(11), 2019
PMID: 31212645

The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review.
Ambrosini YM, Borcherding D, Kanthasamy A, Kim HJ, Willette AA, Jergens A, Allenspach K, Mochel JP., Front Aging Neurosci 11(), 2019
PMID: 31275138

Association of Parkinson's disease and treatment with aminosalicylates in inflammatory bowel disease: a cross-sectional study in a Spain drug dispensation records.
Pinel Ríos J, Madrid Navarro CJ, Pérez Navarro MJ, Cabello Tapia MJ, Piña Vera MJ, Campos Arillo V, Gómez García MR, Mínguez Castellanos A, Escamilla Sevilla F., BMJ Open 9(6), 2019
PMID: 31221869

Infectious Etiologies of Parkinsonism: Pathomechanisms and Clinical Implications.
Limphaibool N, Iwanowski P, Holstad MJV, Kobylarek D, Kozubski W., Front Neurol 10(), 2019
PMID: 31275235

Potential of Prebiotic Butyrogenic Fibers in Parkinson's Disease.
Cantu-Jungles TM, Rasmussen HE, Hamaker BR., Front Neurol 10(), 2019
PMID: 31281287

Distal Consequences of Oral Inflammation.
Konkel JE, O'Boyle C, Krishnan S., Front Immunol 10(), 2019
PMID: 31293577

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH, Chen CC, Chiang HL, Liou JM, Chang CM, Lu TP, Chuang EY, Tai YC, Cheng C, Lin HY, Wu MS., J Neuroinflammation 16(1), 2019
PMID: 31248424

Dietary fructose-induced gut dysbiosis promotes mouse hippocampal neuroinflammation: a benefit of short-chain fatty acids.
Li JM, Yu R, Zhang LP, Wen SY, Wang SJ, Zhang XY, Xu Q, Kong LD., Microbiome 7(1), 2019
PMID: 31255176

Parkinson's Disease: The Emerging Role of Gut Dysbiosis, Antibiotics, Probiotics, and Fecal Microbiota Transplantation.
Dutta SK, Verma S, Jain V, Surapaneni BK, Vinayek R, Phillips L, Nair PP., J Neurogastroenterol Motil 25(3), 2019
PMID: 31327219

Single-Cell Glia and Neuron Gene Expression in the Central Amygdala in Opioid Withdrawal Suggests Inflammation With Correlated Gut Dysbiosis.
O'Sullivan SJ, Malahias E, Park J, Srivastava A, Reyes BAS, Gorky J, Vadigepalli R, Van Bockstaele EJ, Schwaber JS., Front Neurosci 13(), 2019
PMID: 31333398

Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China.
Li C, Cui L, Yang Y, Miao J, Zhao X, Zhang J, Cui G, Zhang Y., Front Mol Neurosci 12(), 2019
PMID: 31354427

The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling.
Brown DG, Soto R, Yandamuri S, Stone C, Dickey L, Gomes-Neto JC, Pastuzyn ED, Bell R, Petersen C, Buhrke K, Fujinami RS, O'Connell RM, Stephens WZ, Shepherd JD, Lane TE, Round JL., Elife 8(), 2019
PMID: 31309928

Gut Microbiome: Profound Implications for Diet and Disease.
Hills RD, Pontefract BA, Mishcon HR, Black CA, Sutton SC, Theberge CR., Nutrients 11(7), 2019
PMID: 31315227

Lipid and immune abnormalities causing age-dependent neurodegeneration and Parkinson's disease.
Hallett PJ, Engelender S, Isacson O., J Neuroinflammation 16(1), 2019
PMID: 31331333

Massive metagenomic data analysis using abundance-based machine learning.
Harris ZN, Dhungel E, Mosior M, Ahn TH., Biol Direct 14(1), 2019
PMID: 31370905

Altered Gut Microbiome in Parkinson's Disease and the Influence of Lipopolysaccharide in a Human α-Synuclein Over-Expressing Mouse Model.
Gorecki AM, Preskey L, Bakeberg MC, Kenna JE, Gildenhuys C, MacDougall G, Dunlop SA, Mastaglia FL, Akkari PA, Koengten F, Anderton RS., Front Neurosci 13(), 2019
PMID: 31440136

High-throughput 16S rRNA gene sequencing reveals that 6-hydroxydopamine affects gut microbial environment.
Choi JG, Huh E, Kim N, Kim DH, Oh MS., PLoS One 14(8), 2019
PMID: 31404072

Physiological responses of insects to microbial fermentation products: Insights from the interactions between Drosophila and acetic acid.
Kim G, Huang JH, McMullen JG, Newell PD, Douglas AE., J Insect Physiol 106(pt 1), 2018
PMID: 28522417

The microbiome regulates amygdala-dependent fear recall.
Hoban AE, Stilling RM, Moloney G, Shanahan F, Dinan TG, Clarke G, Cryan JF., Mol Psychiatry 23(5), 2018
PMID: 28507320

Recent developments in understanding the role of the gut microbiota in brain health and disease.
Sherwin E, Dinan TG, Cryan JF., Ann N Y Acad Sci 1420(1), 2018
PMID: 28768369

How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology.
Borghammer P., Mov Disord 33(1), 2018
PMID: 28843014

The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A, Pandey U, Wicke T, Sixel-Döring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P., Mov Disord 33(1), 2018
PMID: 28843021

Harnessing Gut Microbes for Mental Health: Getting From Here to There.
Bruce-Keller AJ, Salbaum JM, Berthoud HR., Biol Psychiatry 83(3), 2018
PMID: 29031410

Impacts of the Human Gut Microbiome on Therapeutics.
Vázquez-Baeza Y, Callewaert C, Debelius J, Hyde E, Marotz C, Morton JT, Swafford A, Vrbanac A, Dorrestein PC, Knight R., Annu Rev Pharmacol Toxicol 58(), 2018
PMID: 28968189

Nutritional habits, risk, and progression of Parkinson disease.
Erro R, Brigo F, Tamburin S, Zamboni M, Antonini A, Tinazzi M., J Neurol 265(1), 2018
PMID: 29018983

Does Parkinson's disease start in the gut?
Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, Derkinderen P, Beach TG., Acta Neuropathol 135(1), 2018
PMID: 29039141

Altered gut microbiome and metabolome in patients with multiple system atrophy.
Tan AH, Chong CW, Song SL, Teh CSJ, Yap IKS, Loke MF, Tan YQ, Yong HS, Mahadeva S, Lang AE, Lim SY., Mov Disord 33(1), 2018
PMID: 29083071

In vivo models of alpha-synuclein transmission and propagation.
Recasens A, Ulusoy A, Kahle PJ, Di Monte DA, Dehay B., Cell Tissue Res 373(1), 2018
PMID: 29185072

Tonsillectomy and risk of Parkinson's disease: A danish nationwide population-based cohort study.
Svensson E, Henderson VW, Szépligeti S, Stokholm MG, Klug TE, Sørensen HT, Borghammer P., Mov Disord 33(2), 2018
PMID: 29193401

The Impact of Long-Term Intake of Phenolic Compounds-Rich Grape Pomace on Rat Gut Microbiota.
Chacar S, Itani T, Hajal J, Saliba Y, Louka N, Faivre JF, Maroun R, Fares N., J Food Sci 83(1), 2018
PMID: 29227528

Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner.
Thion MS, Low D, Silvin A, Chen J, Grisel P, Schulte-Schrepping J, Blecher R, Ulas T, Squarzoni P, Hoeffel G, Coulpier F, Siopi E, David FS, Scholz C, Shihui F, Lum J, Amoyo AA, Larbi A, Poidinger M, Buttgereit A, Lledo PM, Greter M, Chan JKY, Amit I, Beyer M, Schultze JL, Schlitzer A, Pettersson S, Ginhoux F, Garel S., Cell 172(3), 2018
PMID: 29275859

EBI Metagenomics in 2017: enriching the analysis of microbial communities, from sequence reads to assemblies.
Mitchell AL, Scheremetjew M, Denise H, Potter S, Tarkowska A, Qureshi M, Salazar GA, Pesseat S, Boland MA, Hunter FMI, Ten Hoopen P, Alako B, Amid C, Wilkinson DJ, Curtis TP, Cochrane G, Finn RD., Nucleic Acids Res 46(d1), 2018
PMID: 29069476

The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".
Pröbstel AK, Baranzini SE., Neurotherapeutics 15(1), 2018
PMID: 29147991

An introduction to the microbiome and MS.
Trott S, King IL., Mult Scler 24(1), 2018
PMID: 29307298

Microbiome, Immunomodulation, and the Neuronal System.
Marietta E, Horwath I, Taneja V., Neurotherapeutics 15(1), 2018
PMID: 29313275

Microbiota Signaling Pathways that Influence Neurologic Disease.
Cox LM, Weiner HL., Neurotherapeutics 15(1), 2018
PMID: 29340928

Prion-like propagation of pathology in Parkinson disease.
Volpicelli-Daley L, Brundin P., Handb Clin Neurol 153(), 2018
PMID: 29887143

Stomaching the Possibility of a Pathogenic Role for Helicobacter pylori in Parkinson's Disease.
McGee DJ, Lu XH, Disbrow EA., J Parkinsons Dis 8(3), 2018
PMID: 29966206

The Gut and Parkinson's Disease: Hype or Hope?
Scheperjans F, Derkinderen P, Borghammer P., J Parkinsons Dis 8(s1), 2018
PMID: 30584161

Therapies to Slow, Stop, or Reverse Parkinson's Disease.
Foltynie T, Langston JW., J Parkinsons Dis 8(s1), 2018
PMID: 30584162

Gut microbiota in cardiovascular disease and heart failure.
Kitai T, Tang WHW., Clin Sci (Lond) 132(1), 2018
PMID: 29326279

Interactions between species introduce spurious associations in microbiome studies.
Menon R, Ramanan V, Korolev KS., PLoS Comput Biol 14(1), 2018
PMID: 29338008

Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology.
Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, Sandoval IM, Patterson JR, O'Mara A, Yonkers R, Kordower JH., Neurobiol Dis 112(), 2018
PMID: 29341898

Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice.
Choi JG, Kim N, Ju IG, Eo H, Lim SM, Jang SE, Kim DH, Oh MS., Sci Rep 8(1), 2018
PMID: 29352191

Novel models for Parkinson's disease and their impact on future drug discovery.
Trigo-Damas I, Del Rey NL, Blesa J., Expert Opin Drug Discov 13(3), 2018
PMID: 29363335

Targeting Cellular Stress Mechanisms and Metabolic Homeostasis by Chinese Herbal Drugs for Neuroprotection.
Ting HC, Chang CY, Lu KY, Chuang HM, Tsai SF, Huang MH, Liu CA, Lin SZ, Harn HJ., Molecules 23(2), 2018
PMID: 29382106

Parkinson's disease from the gut.
Liddle RA., Brain Res 1693(pt b), 2018
PMID: 29360467

Overview and systematic review of studies of microbiome in schizophrenia and bipolar disorder.
Nguyen TT, Kosciolek T, Eyler LT, Knight R, Jeste DV., J Psychiatr Res 99(), 2018
PMID: 29407287

Effect of a neural relay on liver regeneration in mice: activation of serotonin release from the gastrointestinal tract.
Inoue R, Kamimura K, Nagoya T, Sakai N, Yokoo T, Goto R, Ogawa K, Shinagawa-Kobayashi Y, Watanabe-Mori Y, Sakamaki A, Abe S, Kamimura H, Miyamura N, Nishina H, Terai S., FEBS Open Bio 8(3), 2018
PMID: 29511622

Immunologic treatment of Parkinson's disease.
Jankovic J., Immunotherapy 10(2), 2018
PMID: 29260621

Does Parkinson's disease start in the gut?
Gershanik OS., Arq Neuropsiquiatr 76(2), 2018
PMID: 29489958

Neuroprotective effect of a new photobiomodulation technique against Aβ25-35 peptide-induced toxicity in mice: Novel hypothesis for therapeutic approach of Alzheimer's disease suggested.
Blivet G, Meunier J, Roman FJ, Touchon J., Alzheimers Dement (N Y) 4(), 2018
PMID: 29955652

Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.
Garrido-Gil P, Rodriguez-Perez AI, Dominguez-Meijide A, Guerra MJ, Labandeira-Garcia JL., Mol Neurobiol 55(9), 2018
PMID: 29404956

How the microbiome challenges our concept of self.
Rees T, Bosch T, Douglas AE., PLoS Biol 16(2), 2018
PMID: 29425197

Flammulina velutipes polysaccharides improve scopolamine-induced learning and memory impairment in mice by modulating gut microbiota composition.
Su A, Yang W, Zhao L, Pei F, Yuan B, Zhong L, Ma G, Hu Q., Food Funct 9(3), 2018
PMID: 29431777

'All disease begins in the gut': was Hippocrates right?
Lyon L., Brain (), 2018
PMID: 29444202

A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease.
Mulak A., Mov Disord 33(3), 2018
PMID: 29436731

Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson's disease.
Zhang J, Culp ML, Craver JG, Darley-Usmar V., J Neurochem 144(6), 2018
PMID: 29341130

2017 Year in Review and Message from the Editors to Our Reviewers.
Pulst SM, Johnson NE, Pandolfo M, Roos RP, Vance JM., Neurol Genet 4(1), 2018
PMID: 29552636

Gut Microbiota: An Integral Moderator in Health and Disease.
Feng Q, Chen WD, Wang YD., Front Microbiol 9(), 2018
PMID: 29515527

Lipopolysaccharide Associates with Amyloid Plaques, Neurons and Oligodendrocytes in Alzheimer's Disease Brain: A Review.
Zhan X, Stamova B, Sharp FR., Front Aging Neurosci 10(), 2018
PMID: 29520228

Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.
Pretorius E, Page MJ, Mbotwe S, Kell DB., PLoS One 13(3), 2018
PMID: 29494603

Of Microbes and Minds: A Narrative Review on the Second Brain Aging.
Calvani R, Picca A, Lo Monaco MR, Landi F, Bernabei R, Marzetti E., Front Med (Lausanne) 5(), 2018
PMID: 29552561

Environmental and Genetic Variables Influencing Mitochondrial Health and Parkinson's Disease Penetrance.
Zanon A, Pramstaller PP, Hicks AA, Pichler I., Parkinsons Dis 2018(), 2018
PMID: 29707191

Hyperglycemia drives intestinal barrier dysfunction and risk for enteric infection.
Thaiss CA, Levy M, Grosheva I, Zheng D, Soffer E, Blacher E, Braverman S, Tengeler AC, Barak O, Elazar M, Ben-Zeev R, Lehavi-Regev D, Katz MN, Pevsner-Fischer M, Gertler A, Halpern Z, Harmelin A, Aamar S, Serradas P, Grosfeld A, Shapiro H, Geiger B, Elinav E., Science 359(6382), 2018
PMID: 29519916

Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome?
Newberry F, Hsieh SY, Wileman T, Carding SR., Clin Sci (Lond) 132(5), 2018
PMID: 29523751

Virus-like particles and enterovirus antigen found in the brainstem neurons of Parkinson's disease.
Dourmashkin RR, McCall SA, Dourmashkin N, Hannah MJ., F1000Res 7(), 2018
PMID: 29899977

The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates.
Franceschi C, Garagnani P, Morsiani C, Conte M, Santoro A, Grignolio A, Monti D, Capri M, Salvioli S., Front Med (Lausanne) 5(), 2018
PMID: 29662881

Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.
Edington CD, Chen WLK, Geishecker E, Kassis T, Soenksen LR, Bhushan BM, Freake D, Kirschner J, Maass C, Tsamandouras N, Valdez J, Cook CD, Parent T, Snyder S, Yu J, Suter E, Shockley M, Velazquez J, Velazquez JJ, Stockdale L, Papps JP, Lee I, Vann N, Gamboa M, LaBarge ME, Zhong Z, Wang X, Boyer LA, Lauffenburger DA, Carrier RL, Communal C, Tannenbaum SR, Stokes CL, Hughes DJ, Rohatgi G, Trumper DL, Cirit M, Griffith LG., Sci Rep 8(1), 2018
PMID: 29540740

Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons.
Geiszler PC, Ugun-Klusek A, Lawler K, Pardon MC, Yuchun D, Bai L, Daykin CA, Auer DP, Bedford L., Sci Rep 8(1), 2018
PMID: 29555943

Early signs of colonic inflammation, intestinal dysfunction, and olfactory impairments in the rotenone-induced mouse model of Parkinson's disease.
Morais LH, Hara DB, Bicca MA, Poli A, Takahashi RN., Behav Pharmacol 29(2 and 3-spec issue), 2018
PMID: 29543651

Autonomic nervous system network and liver regeneration.
Kamimura K, Inoue R, Nagoya T, Sakai N, Goto R, Ko M, Niwa Y, Terai S., World J Gastroenterol 24(15), 2018
PMID: 29686468

Abundant fish protein inhibits α-synuclein amyloid formation.
Werner T, Kumar R, Horvath I, Scheers N, Wittung-Stafshede P., Sci Rep 8(1), 2018
PMID: 29615738

Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines.
Rea IM, Gibson DS, McGilligan V, McNerlan SE, Alexander HD, Ross OA., Front Immunol 9(), 2018
PMID: 29686666

Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations.
Lang AE, Espay AJ., Mov Disord 33(5), 2018
PMID: 29644751

The Brain-Gut-Microbiome Axis.
Martin CR, Osadchiy V, Kalani A, Mayer EA., Cell Mol Gastroenterol Hepatol 6(2), 2018
PMID: 30023410

Cellular and Molecular Basis of Neurodegeneration in Parkinson Disease.
Zeng XS, Geng WS, Jia JJ, Chen L, Zhang PP., Front Aging Neurosci 10(), 2018
PMID: 29719505

Association between physical fitness, cardiovascular risk factors, and Parkinson's disease.
Müller J, Myers J., Eur J Prev Cardiol 25(13), 2018
PMID: 29667433

Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.
Lombardi VC, De Meirleir KL, Subramanian K, Nourani SM, Dagda RK, Delaney SL, Palotás A., J Nutr Biochem 61(), 2018
PMID: 29886183

Impaired tissue barriers as potential therapeutic targets for Parkinson's disease and amyotrophic lateral sclerosis.
Fang X., Metab Brain Dis 33(4), 2018
PMID: 29681010

Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model.
Hryckowian AJ, Van Treuren W, Smits SA, Davis NM, Gardner JO, Bouley DM, Sonnenburg JL., Nat Microbiol 3(6), 2018
PMID: 29686297

Circadian Rhythm Dysfunction Accelerates Disease Progression in a Mouse Model With Amyotrophic Lateral Sclerosis.
Huang Z, Liu Q, Peng Y, Dai J, Xie Y, Chen W, Long S, Pei Z, Su H, Yao X., Front Neurol 9(), 2018
PMID: 29740382

ELISA method to detect α-synuclein oligomers in cell and animal models.
Lassen LB, Gregersen E, Isager AK, Betzer C, Kofoed RH, Jensen PH., PLoS One 13(4), 2018
PMID: 29698510

Urate inhibits microglia activation to protect neurons in an LPS-induced model of Parkinson's disease.
Bao LH, Zhang YN, Zhang JN, Gu L, Yang HM, Huang YY, Xia N, Zhang H., J Neuroinflammation 15(1), 2018
PMID: 29720230

Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration.
Ghiglieri V, Calabrese V, Calabresi P., Front Neurol 9(), 2018
PMID: 29780350

Antagonizing peroxisome proliferator-activated receptor γ facilitates M1-to-M2 shift of microglia by enhancing autophagy via the LKB1-AMPK signaling pathway.
Ji J, Xue TF, Guo XD, Yang J, Guo RB, Wang J, Huang JY, Zhao XJ, Sun XL., Aging Cell 17(4), 2018
PMID: 29740932

Influence of Commensal Microbiota on the Enteric Nervous System and Its Role in Neurodegenerative Diseases.
Endres K, Schäfer KH., J Innate Immun 10(3), 2018
PMID: 29742516

The Microbiome-Mitochondria Dance in Prodromal Parkinson's Disease.
Cardoso SM, Empadinhas N., Front Physiol 9(), 2018
PMID: 29867531

PLGA Microspheres Loaded with β-Cyclodextrin Complexes of Epigallocatechin-3-Gallate for the Anti-Inflammatory Properties in Activated Microglial Cells.
Cheng CY, Pho QH, Wu XY, Chin TY, Chen CM, Fang PH, Lin YC, Hsieh MF., Polymers (Basel) 10(5), 2018
PMID: 30966553

Postnatal colonization with human "infant-type" Bifidobacterium species alters behavior of adult gnotobiotic mice.
Luk B, Veeraragavan S, Engevik M, Balderas M, Major A, Runge J, Luna RA, Versalovic J., PLoS One 13(5), 2018
PMID: 29763437

Neuron-specific regulation of superoxide dismutase amid pathogen-induced gut dysbiosis.
Horspool AM, Chang HC., Redox Biol 17(), 2018
PMID: 29857312

Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
Pellegrini C, Antonioli L, Colucci R, Blandizzi C, Fornai M., Acta Neuropathol 136(3), 2018
PMID: 29797112

Emerging disease-modifying strategies targeting α-synuclein for the treatment of Parkinson's disease.
O'Hara DM, Kalia SK, Kalia LV., Br J Pharmacol 175(15), 2018
PMID: 29722028

Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
Caputi V, Giron MC., Int J Mol Sci 19(6), 2018
PMID: 29882798

Functional variation in the gut microbiome of wild Drosophila populations.
Bost A, Martinson VG, Franzenburg S, Adair KL, Albasi A, Wells MT, Douglas AE., Mol Ecol 27(13), 2018
PMID: 29802796

The enteric nervous system in PD: gateway, bystander victim, or source of solutions.
Shannon K, Vanden Berghe P., Cell Tissue Res 373(1), 2018
PMID: 29936550

Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism.
Soto M, Herzog C, Pacheco JA, Fujisaka S, Bullock K, Clish CB, Kahn CR., Mol Psychiatry 23(12), 2018
PMID: 29910467

Genomic convergence of locus-based GWAS meta-analysis identifies AXIN1 as a novel Parkinson's gene.
Saeed M., Immunogenetics 70(9), 2018
PMID: 29923028

Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML, Fournier C, Houser MC, Tansey M, Glass J, Hertzberg VS., Biol Res Nurs 20(5), 2018
PMID: 29925252

Protein Hydrolysates' Absorption Characteristics in the Dynamic Small Intestine In Vivo.
He Y, Shen L, Ma C, Chen M, Pan Y, Yin L, Zhou J, Lei X, Ren Q, Duan Y, Zhang H, Ma H., Molecules 23(7), 2018
PMID: 29966316

Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson's disease.
Chen QQ, Haikal C, Li W, Li MT, Wang ZY, Li JY., Transl Neurodegener 7(), 2018
PMID: 29988485

The gut-liver axis and the intersection with the microbiome.
Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R., Nat Rev Gastroenterol Hepatol 15(7), 2018
PMID: 29748586

Special issue "Parkinson's disease".
Braak H, Del Tredici-Braak K, Gasser T., Cell Tissue Res 373(1), 2018
PMID: 29882128

Telomere shortening correlates with leukemic stem cell burden at diagnosis of chronic myeloid leukemia.
Bouillon AS, Ventura Ferreira MS, Awad SA, Richter J, Hochhaus A, Kunzmann V, Dengler J, Janssen J, Ossenkoppele G, Westerweel PE, Te Boekhorst PAW, Mahon FX, Hjorth-Hansen H, Isfort S, Fioretos T, Hummel S, Schemionek M, Wilop S, Koschmieder S, Saußele S, Mustjoki S, Beier F, Brümmendorf TH., Blood Adv 2(13), 2018
PMID: 29980572

Gastrointestinal microbiota contributes to the development of murine transfusion-related acute lung injury.
Kapur R, Kim M, Rebetz J, Hallström B, Björkman JT, Takabe-French A, Kim N, Liu J, Shanmugabhavananthan S, Milosevic S, McVey MJ, Speck ER, Semple JW., Blood Adv 2(13), 2018
PMID: 29991496

Parkinson's disease: what the model systems have taught us so far.
Ghatak S, Trudler D, Dolatabadi N, Ambasudhan R., J Genet 97(3), 2018
PMID: 30027906

The microbiome and inborn errors of metabolism: Why we should look carefully at their interplay?
Colonetti K, Roesch LF, Schwartz IVD., Genet Mol Biol 41(3), 2018
PMID: 30235399

Noninvasive options for 'wearing-off' in Parkinson's disease: a clinical consensus from a panel of UK Parkinson's disease specialists.
Fackrell R, Carroll CB, Grosset DG, Mohamed B, Reddy P, Parry M, Chaudhuri KR, Foltynie T., Neurodegener Dis Manag 8(5), 2018
PMID: 29975112

Rethinking the Role of the Nervous System: Lessons From the Hydra Holobiont.
Klimovich AV, Bosch TCG., Bioessays 40(9), 2018
PMID: 29989180

Age-related changes in the gut microbiota influence systemic inflammation and stroke outcome.
Spychala MS, Venna VR, Jandzinski M, Doran SJ, Durgan DJ, Ganesh BP, Ajami NJ, Putluri N, Graf J, Bryan RM, McCullough LD., Ann Neurol 84(1), 2018
PMID: 29733457

Effects of Sub-Chronic MPTP Exposure on Behavioral and Cognitive Performance and the Microbiome of Wild-Type and mGlu8 Knockout Female and Male Mice.
Torres ERS, Akinyeke T, Stagaman K, Duvoisin RM, Meshul CK, Sharpton TJ, Raber J., Front Behav Neurosci 12(), 2018
PMID: 30072879

The Gut Microbiota and Healthy Aging: A Mini-Review.
Kim S, Jazwinski SM., Gerontology 64(6), 2018
PMID: 30025401

Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism.
Zarrinpar A, Chaix A, Xu ZZ, Chang MW, Marotz CA, Saghatelian A, Knight R, Panda S., Nat Commun 9(1), 2018
PMID: 30030441

Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease.
Richards RI, Robertson SA, Kastner DL., Hum Mol Genet 27(r2), 2018
PMID: 29684205

Anti-Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease.
Peter I, Dubinsky M, Bressman S, Park A, Lu C, Chen N, Wang A., JAMA Neurol 75(8), 2018
PMID: 29710331

Neurotransmitter modulation by the gut microbiota.
Strandwitz P., Brain Res 1693(pt b), 2018
PMID: 29903615

Tree Nut Consumption and Adipose Tissue Mass: Mechanisms of Action.
Tindall AM, Petersen KS, Lamendella R, Shearer GC, Murray-Kolb LE, Proctor DN, Kris-Etherton PM., Curr Dev Nutr 2(11), 2018
PMID: 30488045

Gut bacterial composition in a mouse model of Parkinson's disease.
Perez-Pardo P, Dodiya HB, Engen PA, Naqib A, Forsyth CB, Green SJ, Garssen J, Keshavarzian A, Kraneveld AD., Benef Microbes 9(5), 2018
PMID: 30099890

The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue.
Kirby TO, Ochoa-Repáraz J., Med Sci (Basel) 6(3), 2018
PMID: 30149548

Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M, Boehme M, Lyte JM, Wiley N, Strain C, O'Sullivan O, Clarke G, Stanton C, Dinan TG, Cryan JF., J Physiol 596(20), 2018
PMID: 30066368

The Microbiome Regulates Pulmonary Responses to Ozone in Mice.
Cho Y, Abu-Ali G, Tashiro H, Kasahara DI, Brown TA, Brand JD, Mathews JA, Huttenhower C, Shore SA., Am J Respir Cell Mol Biol 59(3), 2018
PMID: 29529379

Neuroimmune mechanisms of psychostimulant and opioid use disorders.
Hofford RS, Russo SJ, Kiraly DD., Eur J Neurosci (), 2018
PMID: 30179286

The role of gut microbiota in lupus: what we know in 2018?
Ruiz L, López P, Suárez A, Sánchez B, Margolles A., Expert Rev Clin Immunol 14(10), 2018
PMID: 30173572

The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence.
Lee K, Vuong HE, Nusbaum DJ, Hsiao EY, Evans CJ, Taylor AMW., Neuropsychopharmacology 43(13), 2018
PMID: 30258112

Emerging Role of Diet and Microbiota Interactions in Neuroinflammation.
Janakiraman M, Krishnamoorthy G., Front Immunol 9(), 2018
PMID: 30254641

Gut-Brain Psychology: Rethinking Psychology From the Microbiota-Gut-Brain Axis.
Liang S, Wu X, Jin F., Front Integr Neurosci 12(), 2018
PMID: 30271330

Appendectomy and risk of Parkinson's disease in two large prospective cohorts of men and women.
Palacios N, Hughes KC, Cereda E, Schwarzschild MA, Ascherio A., Mov Disord 33(9), 2018
PMID: 30218460

The intestinal microbiome and Alzheimer's disease: A review.
Li Z, Zhu H, Zhang L, Qin C., Animal Model Exp Med 1(3), 2018
PMID: 30891563

Converging pathways in neurodegeneration, from genetics to mechanisms.
Gan L, Cookson MR, Petrucelli L, La Spada AR., Nat Neurosci 21(10), 2018
PMID: 30258237

Enteric Neurodegeneration is Mediated Through Independent Neuritic and Somal Mechanisms in Rotenone and MPP+ Toxicity.
Virga DM, Capps J, Vohra BPS., Neurochem Res 43(12), 2018
PMID: 30259276

The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
Jiang T, Li G, Xu J, Gao S, Chen X., Front Immunol 9(), 2018
PMID: 30319601

A Metabolomic-Based Evaluation of the Role of Commensal Microbiota throughout the Gastrointestinal Tract in Mice.
Yamamoto Y, Nakanishi Y, Murakami S, Aw W, Tsukimi T, Nozu R, Ueno M, Hioki K, Nakahigashi K, Hirayama A, Sugimoto M, Soga T, Ito M, Tomita M, Fukuda S., Microorganisms 6(4), 2018
PMID: 30274293

Understanding Neurogastroenterology From Neuroimaging Perspective: A Comprehensive Review of Functional and Structural Brain Imaging in Functional Gastrointestinal Disorders.
Kano M, Dupont P, Aziz Q, Fukudo S., J Neurogastroenterol Motil 24(4), 2018
PMID: 30041284

Microglial signatures and their role in health and disease.
Butovsky O, Weiner HL., Nat Rev Neurosci 19(10), 2018
PMID: 30206328

Taming the beasts within.
Martinez J., Nat Microbiol 3(10), 2018
PMID: 30254330

Impact of vegan diets on gut microbiota: An update on the clinical implications.
Wong MW, Yi CH, Liu TT, Lei WY, Hung JS, Lin CL, Lin SZ, Chen CL., Ci Ji Yi Xue Za Zhi 30(4), 2018
PMID: 30305781

Defining Dysbiosis in Disorders of Movement and Motivation.
Fields CT, Sampson TR, Bruce-Keller AJ, Kiraly DD, Hsiao EY, de Vries GJ., J Neurosci 38(44), 2018
PMID: 30381433

Peripheral immune system in aging and Alzheimer's disease.
Cao W, Zheng H., Mol Neurodegener 13(1), 2018
PMID: 30285785

Oleoylethanolamide treatment affects gut microbiota composition and the expression of intestinal cytokines in Peyer's patches of mice.
Di Paola M, Bonechi E, Provensi G, Costa A, Clarke G, Ballerini C, De Filippo C, Passani MB., Sci Rep 8(1), 2018
PMID: 30291258

The Gut-Microglia Connection: Implications for Central Nervous System Diseases.
Wang Y, Wang Z, Wang Y, Li F, Jia J, Song X, Qin S, Wang R, Jin F, Kitazato K, Wang Y., Front Immunol 9(), 2018
PMID: 30344525

Connection between Systemic Inflammation and Neuroinflammation Underlies Neuroprotective Mechanism of Several Phytochemicals in Neurodegenerative Diseases.
Wang J, Song Y, Chen Z, Leng SX., Oxid Med Cell Longev 2018(), 2018
PMID: 30402203

Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease.
Troncoso-Escudero P, Parra A, Nassif M, Vidal RL., Front Neurol 9(), 2018
PMID: 30459700

Cannabis Therapeutics and the Future of Neurology.
Russo EB., Front Integr Neurosci 12(), 2018
PMID: 30405366

Gastrointestinal Dysfunction in Parkinson's Disease.
Pfeiffer RF., Curr Treat Options Neurol 20(12), 2018
PMID: 30361783

Antibiotic and Modulation of Microbiota: A New Paradigm?
Rizzatti G, Ianiro G, Gasbarrini A., J Clin Gastroenterol 52 Suppl 1, Proceedings from the 9th Probiotics, Prebio(), 2018
PMID: 29912755

What is the Evidence That Parkinson's Disease is a Prion Disorder, Which Originates in the Gut?
Kujawska M, Jodynis-Liebert J., Int J Mol Sci 19(11), 2018
PMID: 30424585

Central Nervous System Responses to Simulated Galactic Cosmic Rays.
Cekanaviciute E, Rosi S, Costes SV., Int J Mol Sci 19(11), 2018
PMID: 30463349

Commensal Bacteria-Specific CD4+ T Cell Responses in Health and Disease.
Sorini C, Cardoso RF, Gagliani N, Villablanca EJ., Front Immunol 9(), 2018
PMID: 30524431

Kinetic Modeling of pH-Dependent Oxidation of Dopamine by Iron and Its Relevance to Parkinson's Disease.
Sun Y, Pham AN, Hare DJ, Waite TD., Front Neurosci 12(), 2018
PMID: 30534046

Complete Genome Sequencing of Lactobacillus plantarum ZLP001, a Potential Probiotic That Enhances Intestinal Epithelial Barrier Function and Defense Against Pathogens in Pigs.
Zhang W, Ji H, Zhang D, Liu H, Wang S, Wang J, Wang Y., Front Physiol 9(), 2018
PMID: 30542296

Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium.
Sharkey KA, Beck PL, McKay DM., Nat Rev Gastroenterol Hepatol 15(12), 2018
PMID: 30069036

Polyphenols-gut microbiota interplay and brain neuromodulation.
Filosa S, Di Meo F, Crispi S., Neural Regen Res 13(12), 2018
PMID: 30323120

Association of gut microbiota composition and function with a senescence-accelerated mouse model of Alzheimer's Disease using 16S rRNA gene and metagenomic sequencing analysis.
Peng W, Yi P, Yang J, Xu P, Wang Y, Zhang Z, Huang S, Wang Z, Zhang C., Aging (Albany NY) 10(12), 2018
PMID: 30562162

Oxidative Stress and the Microbiota-Gut-Brain Axis.
Dumitrescu L, Popescu-Olaru I, Cozma L, Tulbă D, Hinescu ME, Ceafalan LC, Gherghiceanu M, Popescu BO., Oxid Med Cell Longev 2018(), 2018
PMID: 30622664

Advances in Parkinson's Disease: 200 Years Later.
Del Rey NL, Quiroga-Varela A, Garbayo E, Carballo-Carbajal I, Fernández-Santiago R, Monje MHG, Trigo-Damas I, Blanco-Prieto MJ, Blesa J., Front Neuroanat 12(), 2018
PMID: 30618654

A Metabologenomic Approach Reveals Changes in the Intestinal Environment of Mice Fed on American Diet.
Ishii C, Nakanishi Y, Murakami S, Nozu R, Ueno M, Hioki K, Aw W, Hirayama A, Soga T, Ito M, Tomita M, Fukuda S., Int J Mol Sci 19(12), 2018
PMID: 30562947

Production of the Neurotoxin Salsolinol by a Gut-Associated Bacterium and Its Modulation by Alcohol.
Villageliú DN, Borts DJ, Lyte M., Front Microbiol 9(), 2018
PMID: 30619171

Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy.
Valdinocci D, Radford RAW, Goulding M, Hayashi J, Chung RS, Pountney DL., Int J Mol Sci 19(12), 2018
PMID: 30572656

Quantification of hydrogen production by intestinal bacteria that are specifically dysregulated in Parkinson's disease.
Suzuki A, Ito M, Hamaguchi T, Mori H, Takeda Y, Baba R, Watanabe T, Kurokawa K, Asakawa S, Hirayama M, Ohno K., PLoS One 13(12), 2018
PMID: 30586410

Parkinson disease: Could gut microbiota influence severity of Parkinson disease?
Malkki H., Nat Rev Neurol 13(2), 2017
PMID: 27982042

Top Altmetric Scores in the Parkinson's Disease Literature.
Araújo R, Sorensen AA, Konkiel S, Bloem BR., J Parkinsons Dis 7(1), 2017
PMID: 28222540

The Potential Role of Gut-Derived Inflammation in Multiple System Atrophy.
Engen PA, Dodiya HB, Naqib A, Forsyth CB, Green SJ, Voigt RM, Kordower JH, Mutlu EA, Shannon KM, Keshavarzian A., J Parkinsons Dis 7(2), 2017
PMID: 28234259

The Gut Microbiota and Alzheimer's Disease.
Jiang C, Li G, Huang P, Liu Z, Zhao B., J Alzheimers Dis 58(1), 2017
PMID: 28372330

Altered Gut Microbiota in a Mouse Model of Alzheimer's Disease.
Zhang L, Wang Y, Xiayu X, Shi C, Chen W, Song N, Fu X, Zhou R, Xu YF, Huang L, Zhu H, Han Y, Qin C., J Alzheimers Dis 60(4), 2017
PMID: 29036812

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease?
Thirtamara-Rajamani K, Li P, Escobar Galvis ML, Labrie V, Brundin P, Brundin L., J Parkinsons Dis 7(4), 2017
PMID: 29103054

Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson's Disease.
Yang X, Qian Y, Xu S, Song Y, Xiao Q., Front Aging Neurosci 9(), 2017
PMID: 29358918

Bacterial Signaling to the Nervous System through Toxins and Metabolites.
Yang NJ, Chiu IM., J Mol Biol 429(5), 2017
PMID: 28065740

Gut microbiota in 2016: A banner year for gut microbiota research.
Garrett WS., Nat Rev Gastroenterol Hepatol 14(2), 2017
PMID: 28074073

Movement disorders in 2016: Progress in Parkinson disease and other movement disorders.
Jankovic J., Nat Rev Neurol 13(2), 2017
PMID: 28084323

Gut microbiota: A player in aging and a target for anti-aging intervention.
Vaiserman AM, Koliada AK, Marotta F., Ageing Res Rev 35(), 2017
PMID: 28109835

Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins.
Olanow CW, Kordower JH., Mov Disord 32(2), 2017
PMID: 28218461

Parkinson's disease: Oh my gut!
Del Rey NL, Blesa J., Mov Disord 32(3), 2017
PMID: 28151555

Gut microbiota: Implications in Parkinson's disease.
Parashar A, Udayabanu M., Parkinsonism Relat Disord 38(), 2017
PMID: 28202372

Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM, Debelius JW, Morton JT, Wissemann WT, Lewis MR, Wallen ZD, Peddada SD, Factor SA, Molho E, Zabetian CP, Knight R, Payami H., Mov Disord 32(5), 2017
PMID: 28195358

The chicken or the egg dilemma: intestinal dysbiosis in multiple sclerosis.
Ochoa-Repáraz J, Magori K, Kasper LH., Ann Transl Med 5(6), 2017
PMID: 28462225

Gut Feelings on Parkinson's and Depression.
Dinan TG, Cryan JF., Cerebrum 2017(), 2017
PMID: 28698775

Dysbiosis and the immune system.
Levy M, Kolodziejczyk AA, Thaiss CA, Elinav E., Nat Rev Immunol 17(4), 2017
PMID: 28260787

Recent advances in treating Parkinson's disease.
Oertel WH., F1000Res 6(), 2017
PMID: 28357055

The Host Microbiome Regulates and Maintains Human Health: A Primer and Perspective for Non-Microbiologists.
Thomas S, Izard J, Walsh E, Batich K, Chongsathidkiet P, Clarke G, Sela DA, Muller AJ, Mullin JM, Albert K, Gilligan JP, DiGuilio K, Dilbarova R, Alexander W, Prendergast GC., Cancer Res 77(8), 2017
PMID: 28292977

The gut microbiome in human neurological disease: A review.
Tremlett H, Bauer KC, Appel-Cresswell S, Finlay BB, Waubant E., Ann Neurol 81(3), 2017
PMID: 28220542

The Microbiome and Human Biology.
Knight R, Callewaert C, Marotz C, Hyde ER, Debelius JW, McDonald D, Sogin ML., Annu Rev Genomics Hum Genet 18(), 2017
PMID: 28375652

Parkinson disease.
Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, Schrag AE, Lang AE., Nat Rev Dis Primers 3(), 2017
PMID: 28332488

Opposite effects of 5-HT/AKH and octopamine on the crop contractions in adult Drosophila melanogaster: Evidence of a double brain-gut serotonergic circuitry.
Solari P, Rivelli N, De Rose F, Picciau L, Murru L, Stoffolano JG, Liscia A., PLoS One 12(3), 2017
PMID: 28334024

Microbial Immuno-Communication in Neurodegenerative Diseases.
Main BS, Minter MR., Front Neurosci 11(), 2017
PMID: 28386215

Gut-Brain Axis and Behavior.
Martin CR, Mayer EA., Nestle Nutr Inst Workshop Ser 88(), 2017
PMID: 28346923

Monocytes, microglia, and CD200-CD200R1 signaling are essential in the transmission of inflammation from the periphery to the central nervous system.
Xie X, Luo X, Liu N, Li X, Lou F, Zheng Y, Ren Y., J Neurochem 141(2), 2017
PMID: 28164283

Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
Quigley EMM., Nat Rev Gastroenterol Hepatol 14(5), 2017
PMID: 28356581

LRRK2 Expression in the Enteric Nervous System: ENSuring Its Significance.
Derkinderen P., Dig Dis Sci 62(4), 2017
PMID: 28224253

Nature Biotechnology's academic spinouts of 2016.
Bouchie A, DeFrancesco L, Sheridan C, Webb S., Nat Biotechnol 35(4), 2017
PMID: 28398323

Media hype: Patient and scientific perspectives on misleading medical news.
Robledo I, Jankovic J., Mov Disord 32(9), 2017
PMID: 28370445

Microbiology: Gut microbes augment neurodegeneration.
Erny D, Prinz M., Nature 544(7650), 2017
PMID: 28405021

Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-naïve Parkinson's disease patients.
Bedarf JR, Hildebrand F, Coelho LP, Sunagawa S, Bahram M, Goeser F, Bork P, Wüllner U., Genome Med 9(1), 2017
PMID: 28449715

C14orf28 downregulated by miR-519d contributes to oncogenicity and regulates apoptosis and EMT in colorectal cancer.
Yang X, Hu Y, Liu Y, Liu W, Zhao X, Liu M, Tang H., Mol Cell Biochem 434(1-2), 2017
PMID: 28455792

A neurorestorative approach to Parkinson's disease.
Diana G, Ciotti MT, Musilli M., Oncotarget 8(21), 2017
PMID: 28423348

Holocranohistochemistry enables the visualization of α-synuclein expression in the murine olfactory system and discovery of its systemic anti-microbial effects.
Tomlinson JJ, Shutinoski B, Dong L, Meng F, Elleithy D, Lengacher NA, Nguyen AP, Cron GO, Jiang Q, Roberson ED, Nussbaum RL, Majbour NK, El-Agnaf OM, Bennett SA, Lagace DC, Woulfe JM, Sad S, Brown EG, Schlossmacher MG., J Neural Transm (Vienna) 124(6), 2017
PMID: 28477284

The bidirectional gut-brain-microbiota axis as a potential nexus between traumatic brain injury, inflammation, and disease.
Sundman MH, Chen NK, Subbian V, Chou YH., Brain Behav Immun 66(), 2017
PMID: 28526435

Metal Transporter Zip14 (Slc39a14) Deletion in Mice Increases Manganese Deposition and Produces Neurotoxic Signatures and Diminished Motor Activity.
Aydemir TB, Kim MH, Kim J, Colon-Perez LM, Banan G, Mareci TH, Febo M, Cousins RJ., J Neurosci 37(25), 2017
PMID: 28536273

Molecular Imaging in Synthetic Biology, and Synthetic Biology in Molecular Imaging.
Gilad AA, Shapiro MG., Mol Imaging Biol 19(3), 2017
PMID: 28213833

Sleep Disturbances in the Prodromal Stage of Parkinson Disease.
Al-Qassabi A, Fereshtehnejad SM, Postuma RB., Curr Treat Options Neurol 19(6), 2017
PMID: 28466429

The Enteric Network: Interactions between the Immune and Nervous Systems of the Gut.
Yoo BB, Mazmanian SK., Immunity 46(6), 2017
PMID: 28636959

Biochemical, Cellular, Physiological, and Pathological Consequences of Human Loss of N-Glycolylneuraminic Acid.
Okerblom J, Varki A., Chembiochem 18(13), 2017
PMID: 28423240

Commentary: Target Intestinal Microbiota to Alleviate Disease Progression in Amyotrophic Lateral Sclerosis.
Sun J., J Neurol Neuromedicine 2(6), 2017
PMID: 29152613

α-Synuclein in gut endocrine cells and its implications for Parkinson's disease.
Chandra R, Hiniker A, Kuo YM, Nussbaum RL, Liddle RA., JCI Insight 2(12), 2017
PMID: 28614796

Individual Amino Acid Supplementation Can Improve Energy Metabolism and Decrease ROS Production in Neuronal Cells Overexpressing Alpha-Synuclein.
Delic V, Griffin JWD, Zivkovic S, Zhang Y, Phan TA, Gong H, Chaput D, Reynes C, Dinh VB, Cruz J, Cvitkovic E, Placides D, Frederic E, Mirzaei H, Stevens SM, Jinwal U, Lee DC, Bradshaw PC., Neuromolecular Med 19(2-3), 2017
PMID: 28620826

Toward a genetic tool development pipeline for host-associated bacteria.
Waller MC, Bober JR, Nair NU, Beisel CL., Curr Opin Microbiol 38(), 2017
PMID: 28624690

16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain.
Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ., Front Aging Neurosci 9(), 2017
PMID: 28676754

Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit.
Tohidpour A, Morgun AV, Boitsova EB, Malinovskaya NA, Martynova GP, Khilazheva ED, Kopylevich NV, Gertsog GE, Salmina AB., Front Cell Infect Microbiol 7(), 2017
PMID: 28676848

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis.
Westfall S, Lomis N, Kahouli I, Dia SY, Singh SP, Prakash S., Cell Mol Life Sci 74(20), 2017
PMID: 28643167

RETRACTED: Enriched environment promotes remyelination and motor function recovery through modulation of HDAC1/2 in mice.
Zheng J, Ding W, Li B, Yang Y., Neurosci Lett 655(), 2017
PMID: 28648457

A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity.
Stolzenberg E, Berry D, Yang, Lee EY, Kroemer A, Kaufman S, Wong GCL, Oppenheim JJ, Sen S, Fishbein T, Bax A, Harris B, Barbut D, Zasloff MA., J Innate Immun 9(5), 2017
PMID: 28651250

The remedy within: will the microbiome fulfill its therapeutic promise?
Thaiss CA, Elinav E., J Mol Med (Berl) 95(10), 2017
PMID: 28656322

An update on the recognition and treatment of autonomic symptoms in Parkinson's disease.
Jost WH., Expert Rev Neurother 17(8), 2017
PMID: 28631489

The microbiome: current and future view of an ancient paradigm.
Neish AS, Pacifici R, Mulle JG, Kraft CS, Stephens DS., Future Microbiol 12(), 2017
PMID: 28660775

Indoleacrylic Acid Produced by Commensal Peptostreptococcus Species Suppresses Inflammation.
Wlodarska M, Luo C, Kolde R, d'Hennezel E, Annand JW, Heim CE, Krastel P, Schmitt EK, Omar AS, Creasey EA, Garner AL, Mohammadi S, O'Connell DJ, Abubucker S, Arthur TD, Franzosa EA, Huttenhower C, Murphy LO, Haiser HJ, Vlamakis H, Porter JA, Xavier RJ., Cell Host Microbe 22(1), 2017
PMID: 28704649

Regulation of inflammation by microbiota interactions with the host.
Blander JM, Longman RS, Iliev ID, Sonnenberg GF, Artis D., Nat Immunol 18(8), 2017
PMID: 28722709

Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
Namasivayam S, Maiga M, Yuan W, Thovarai V, Costa DL, Mittereder LR, Wipperman MF, Glickman MS, Dzutsev A, Trinchieri G, Sher A., Microbiome 5(1), 2017
PMID: 28683818

The emerging science of precision medicine and pharmacogenomics for Parkinson's disease.
Payami H., Mov Disord 32(8), 2017
PMID: 28686320

Teleosts as Model Organisms To Understand Host-Microbe Interactions.
Lescak EA, Milligan-Myhre KC., J Bacteriol 199(15), 2017
PMID: 28439034

Progress toward an integrated understanding of Parkinson's disease.
Rousseaux MWC, Shulman JM, Jankovic J., F1000Res 6(), 2017
PMID: 28751973

An unexplored brain-gut microbiota axis in stroke.
Wen SW, Wong CHY., Gut Microbes 8(6), 2017
PMID: 28640714

The human microbiome.
Blum HE., Adv Med Sci 62(2), 2017
PMID: 28711782

(Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease.
Buford TW., Microbiome 5(1), 2017
PMID: 28709450

Perspective: Neuroregenerative Nutrition.
Steindler DA, Reynolds BA., Adv Nutr 8(4), 2017
PMID: 28710142

Eating Disorders and the Intestinal Microbiota: Mechanisms of Energy Homeostasis and Behavioral Influence.
Glenny EM, Bulik-Sullivan EC, Tang Q, Bulik CM, Carroll IM., Curr Psychiatry Rep 19(8), 2017
PMID: 28676966

Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts.
Itzhaki RF., FASEB J 31(8), 2017
PMID: 28765170

Influence of gut microbiota on neuropsychiatric disorders.
Cenit MC, Sanz Y, Codoñer-Franch P., World J Gastroenterol 23(30), 2017
PMID: 28852308

Biomarker Research in Parkinson's Disease Using Metabolite Profiling.
Havelund JF, Heegaard NHH, Færgeman NJK, Gramsbergen JB., Metabolites 7(3), 2017
PMID: 28800113

Non-CNS pathogenic origin of Parkinson's disease.
Choudhry H, Perlmuter LC., J Neurol 264(9), 2017
PMID: 28808780

Regulation of life span by the gut microbiota in the short-lived African turquoise killifish.
Smith P, Willemsen D, Popkes M, Metge F, Gandiwa E, Reichard M, Valenzano DR., Elife 6(), 2017
PMID: 28826469

Timing the Microbes: The Circadian Rhythm of the Gut Microbiome.
Liang X, FitzGerald GA., J Biol Rhythms 32(6), 2017
PMID: 28862076

Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection.
Labrie V, Brundin P., J Innate Immun 9(5), 2017
PMID: 28866688

Antibiotic-induced perturbations in microbial diversity during post-natal development alters amyloid pathology in an aged APPSWE/PS1ΔE9 murine model of Alzheimer's disease.
Minter MR, Hinterleitner R, Meisel M, Zhang C, Leone V, Zhang X, Oyler-Castrillo P, Zhang X, Musch MW, Shen X, Jabri B, Chang EB, Tanzi RE, Sisodia SS., Sci Rep 7(1), 2017
PMID: 28874832

Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.
Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, Crabtree-Hartman E, Sand IK, Gacias M, Zhu Y, Casaccia P, Cree BAC, Knight R, Mazmanian SK, Baranzini SE., Proc Natl Acad Sci U S A 114(40), 2017
PMID: 28893978

Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice.
Berer K, Gerdes LA, Cekanaviciute E, Jia X, Xiao L, Xia Z, Liu C, Klotz L, Stauffer U, Baranzini SE, Kümpfel T, Hohlfeld R, Krishnamoorthy G, Wekerle H., Proc Natl Acad Sci U S A 114(40), 2017
PMID: 28893994

Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson's disease?
Matsumoto J, Stewart T, Sheng L, Li N, Bullock K, Song N, Shi M, Banks WA, Zhang J., Acta Neuropathol Commun 5(1), 2017
PMID: 28903781

DMARD use is associated with a higher risk of dementia in patients with rheumatoid arthritis: A propensity score-matched case-control study.
Chou MH, Wang JY, Lin CL, Chung WS., Toxicol Appl Pharmacol 334(), 2017
PMID: 28927738

How can computation advance microbiome research?
Nussinov R, Papin JA., PLoS Comput Biol 13(9), 2017
PMID: 28934204

A gut feeling about multiple sclerosis.
Quintana FJ, Prinz M., Proc Natl Acad Sci U S A 114(40), 2017
PMID: 28973867

CD4+ T cells from multiple sclerosis patients respond to a commensal-derived antigen.
Burgess JN, Pant AB, Kasper LH, Colpitts Brass S., Ann Clin Transl Neurol 4(11), 2017
PMID: 29159195

Implications of peptide assemblies in amyloid diseases.
Ke PC, Sani MA, Ding F, Kakinen A, Javed I, Separovic F, Davis TP, Mezzenga R., Chem Soc Rev 46(21), 2017
PMID: 28702523

Prying into the Prion Hypothesis for Parkinson's Disease.
Brundin P, Melki R., J Neurosci 37(41), 2017
PMID: 29021298

Gut Microbiota and Salivary Diagnostics: The Mouth Is Salivating to Tell Us Something.
Kodukula K, Faller DV, Harpp DN, Kanara I, Pernokas J, Pernokas M, Powers WR, Soukos NS, Steliou K, Moos WH., Biores Open Access 6(1), 2017
PMID: 29098118

Agonists for G-protein-coupled receptor 84 (GPR84) alter cellular morphology and motility but do not induce pro-inflammatory responses in microglia.
Wei L, Tokizane K, Konishi H, Yu HR, Kiyama H., J Neuroinflammation 14(1), 2017
PMID: 28974234

Functional Classification of the Gut Microbiota: The Key to Cracking the Microbiota Composition Code: Functional classifications of the gut microbiota reveal previously hidden contributions of indigenous gut bacteria to human health and disease.
Rosen CE, Palm NW., Bioessays 39(12), 2017
PMID: 28976007

The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.
Eskandari-Sedighi G, Daude N, Gapeshina H, Sanders DW, Kamali-Jamil R, Yang J, Shi B, Wille H, Ghetti B, Diamond MI, Janus C, Westaway D., Mol Neurodegener 12(1), 2017
PMID: 28978354

Amino acid supplements and metabolic health: a potential interplay between intestinal microbiota and systems control.
Bifari F, Ruocco C, Decimo I, Fumagalli G, Valerio A, Nisoli E., Genes Nutr 12(), 2017
PMID: 29043007

The Gut Microbiome Feelings of the Brain: A Perspective for Non-Microbiologists.
Lerner A, Neidhöfer S, Matthias T., Microorganisms 5(4), 2017
PMID: 29023380

Structural host-microbiota interaction networks.
Guven-Maiorov E, Tsai CJ, Nussinov R., PLoS Comput Biol 13(10), 2017
PMID: 29023448

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases.
Quigley EMM., Curr Neurol Neurosci Rep 17(12), 2017
PMID: 29039142

Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study.
Minato T, Maeda T, Fujisawa Y, Tsuji H, Nomoto K, Ohno K, Hirayama M., PLoS One 12(11), 2017
PMID: 29091972

[When germs get involved in Parkinson's disease].
Khenniche Y, Lutete E, Bobé P., Med Sci (Paris) 33(11), 2017
PMID: 29200392

Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson's Disease.
Perez-Pardo P, Hartog M, Garssen J, Kraneveld AD., Curr Behav Neurosci Rep 4(4), 2017
PMID: 29201595

Selective killing of Helicobacter pylori with pH-responsive helix-coil conformation transitionable antimicrobial polypeptides.
Xiong M, Bao Y, Xu X, Wang H, Han Z, Wang Z, Liu Y, Huang S, Song Z, Chen J, Peek RM, Yin L, Chen LF, Cheng J., Proc Natl Acad Sci U S A 114(48), 2017
PMID: 29133389

A transatlantic perspective on 20 emerging issues in biological engineering.
Wintle BC, Boehm CR, Rhodes C, Molloy JC, Millett P, Adam L, Breitling R, Carlson R, Casagrande R, Dando M, Doubleday R, Drexler E, Edwards B, Ellis T, Evans NG, Hammond R, Haseloff J, Kahl L, Kuiken T, Lichman BR, Matthewman CA, Napier JA, ÓhÉigeartaigh SS, Patron NJ, Perello E, Shapira P, Tait J, Takano E, Sutherland WJ., Elife 6(), 2017
PMID: 29132504

Probiotic, Prebiotic, and Brain Development.
Cerdó T, Ruíz A, Suárez A, Campoy C., Nutrients 9(11), 2017
PMID: 29135961

Visceral Inflammation and Immune Activation Stress the Brain.
Holzer P, Farzi A, Hassan AM, Zenz G, Jačan A, Reichmann F., Front Immunol 8(), 2017
PMID: 29213271

Vertebrate food products as a potential source of prion-like α-synuclein.
Killinger BA, Labrie V., NPJ Parkinsons Dis 3(), 2017
PMID: 29184902

Microbiota and neurodegenerative diseases.
Marizzoni M, Provasi S, Cattaneo A, Frisoni GB., Curr Opin Neurol 30(6), 2017
PMID: 28906270

Biological and Clinical Implications of Comorbidities in Parkinson's Disease.
Santiago JA, Bottero V, Potashkin JA., Front Aging Neurosci 9(), 2017
PMID: 29255414

The role of microbial amyloid in neurodegeneration.
Friedland RP, Chapman MR., PLoS Pathog 13(12), 2017
PMID: 29267402

Microbiology: Gut bacteria linked to Parkinson's.
, Nature 540(7632), 2016
PMID: 27929009